https://www.selleckchem.com/pr....oducts/tucidinostat-
It does not seem to shorten the duration of oxygen need nor the duration of hospital admission.What is Known• HFNC is being used increasingly in the context of infant bronchiolitis. However, evidence on efficacy and safety are limited. Different published studies involve different disease severities and different pediatric settings.What is New• In this review, we summarize data only from prospective RCTs with the aim to provide guidance on how to use HFNC.PURPOSES The objectives of this study were to investigate differenc
Beğen
Yorum Yap
Paylaş
